Dr. Jarskog is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27599Phone+1 919-843-7683Fax+1 919-445-0234
Education & Training
- University of North Carolina HospitalsResidency, Psychiatry, 1992 - 1997
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1991
Certifications & Licensure
- NC State Medical License 2010 - 2025
- NY State Medical License 2007 - 2011
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Start of enrollment: 2016 Sep 01
- Improving Cognition Via Exercise in Schizophrenia Start of enrollment: 2018 Apr 26
- Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia Start of enrollment: 2017 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 139 citationsCharacterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory.Diana O. Perkins, Jane Leserman, L. Fredrik Jarskog, Karen A. Graham, Janet Kazmer
Schizophrenia Research. 2000-07-07 - 8 citationsAlpha transcranial alternating current stimulation reduces depressive symptoms in people with schizophrenia and auditory hallucinations: a double-blind, randomized pil...Mengsen Zhang, Rachel B Force, Christopher Walker, Sangtae Ahn, L Fredrik Jarskog
Schizophrenia. 2022-12-24 - 80 citationsSchizophrenia: new pathological insights and therapies.L. Fredrik Jarskog, Seiya Miyamoto, Jeffrey A. Lieberman
Annual Review of Medicine. 2007-01-11
Journal Articles
- Targeting Reduced Neural Oscillations in Patients with Schizophrenia by Transcranial Alternating Current StimulationJohn H Gilmore, L Fredrik Jarskog, ScienceDirect
Grant Support
- Novel pharmacotherapy strategies for obesity in schizophreniaNIDDK2016–Present
- Using FMRI To Measure Negative Symptoms In SchizophreniaNational Institute Of Mental Health2009–2010
- BCL-2 Family Protein And Apoptosis In SchizophreniaNational Institute Of Mental Health2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: